JAN 24, 2017 9:45 AM PST

How to rebuild heart's layers with stem cells

Image Credit: Getty Images

A process using human stem cells can generate the epicardium cells that cover the outer surface of a human heart.

“In 2012, we discovered that if we treated human stem cells with chemicals that sequentially activate and inhibit Wnt signaling pathway, they become myocardium muscle cells,” says Xiaojun Lance Lian, assistant professor of biomedical engineering and biology, who is leading the study at Penn State.

Myocardium, the middle of the heart’s three layers, is the thick, muscular part that contracts to drive blood through the body.

The Wnt signaling pathway is a group of signal transduction pathways made of proteins that pass signals into a cell using cell-surface receptors.

“We needed to provide the cardiac progenitor cells with additional information in order for them to generate into epicardium cells, but prior to this study, we didn’t know what that information was,” says Lian. “Now, we know that if we activate the cells’ Wnt signaling pathway again, we can re-drive these cardiac progenitor cells to become epicardium cells, instead of myocardium cells.”

The group’s results, published in Nature Biomedical Engineering, bring them one step closer to regenerating an entire heart wall.

Heart attack damage

The researchers found that the generated epicardium cells were similar to epicardium cells in living humans and those grown in the laboratory.

“The last piece is turning cardiac progenitor cells to endocardium cells (the heart’s inner layer), and we are making progress on that,” says Lian.

The group’s method of generating epicardium cells could be useful in clinical applications, for patients who suffer a heart attack.

“Heart attacks occur due to blockage of blood vessels,” says Lian. “This blockage stops nutrients and oxygen from reaching the heart muscle, and muscle cells die. These muscle cells cannot regenerate themselves, so there is permanent damage, which can cause additional problems.

“These epicardium cells could be transplanted to the patient and potentially repair the damaged region.”

During their study, the researchers engineered the human stem cells to become reporter cells, meaning these cells expressed a fluorescent protein only when they became epicardium cells.

“We treated the cells with different cell signaling molecules, and we found that when we treated them with Wnt signaling activators, they became fluorescent,” says Lian.

Regenerate entire heart wall

Another finding, he says, is that in addition to generating the epicardium cells, the researchers also can keep them proliferating in the lab after treating these cells with a cell-signaling pathway transforming growth factor beta (TGF) inhibitor.

“After 50 days, our cells did not show any signs of decreased proliferation. However, the proliferation of the control cells without the TGF Beta inhibitor started to plateau after the tenth day,” says Lian.

The team will continue working together to further their research on regenerating endocardium cells.

“We are making progress on that inner layer, which will allow us to regenerate an entire heart wall that can be used in tissue engineering for cardiac therapy,” says Lian.

Additional researchers on this project are from the University of Wisconsin, Madison; AstraZeneca, Sweden; and Leiden University Medical Center, the Netherlands.

The National Institutes of Health, the National Science Foundation, Penn State’s College of Engineering, and the University of Wisconsin Stem Cell and Regenerative Medicine Center supported this work.

Source: Penn State

About the Author
MS
Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JAN 27, 2022
Drug Discovery & Development
The way to the heart is through the toilet seat. Casana raises $30million for its blood pressure monitoring toilet seat.
JAN 27, 2022
The way to the heart is through the toilet seat. Casana raises $30million for its blood pressure monitoring toilet seat.
Casana, a healthcare company based out of Rochester, New York, announced early this week that it has raised $3 ...
FEB 22, 2022
Clinical & Molecular DX
Gut Bacteria Imbalances and Heart Disease
FEB 22, 2022
Gut Bacteria Imbalances and Heart Disease
Patients with cardiovascular disease have significant disruptions in their gut microbiomes, says a new study by an inter ...
MAR 18, 2022
Clinical & Molecular DX
Study Indicates Possible Links between Suicide and Undiagnosed Autism
MAR 18, 2022
Study Indicates Possible Links between Suicide and Undiagnosed Autism
The American Foundation for Suicide Prevention reports that over 45,000 Americans died by suicide in 2020, mak ...
APR 11, 2022
Technology
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
APR 11, 2022
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
Cardiac arrest occurs when the heart suddenly stops working, usually leading to the inability to breathe or a loss of co ...
MAY 12, 2022
Clinical & Molecular DX
Researchers Show Influenza Directly Infects the Heart
MAY 12, 2022
Researchers Show Influenza Directly Infects the Heart
Heart complications are often observed in severe or fatal cases of Influenza. These problems can include electrical malf ...
JUN 12, 2022
Neuroscience
Multiple Heart-Related Conditions Triples Dementia Risk
JUN 12, 2022
Multiple Heart-Related Conditions Triples Dementia Risk
People who have multiple cardiometabolic conditions have a three times higher dementia risk than those with a high genet ...
Loading Comments...